New Zealand withdraws dextropropoxyphene products
12 February 2010
Becky Debens
New Zealand has withdrawn all analgesic products containing dextropropoxyphene, following similar moves to restrict their use in Europe and the US.
New Zealand's Medicines Adverse Reactions Committee (MARC), an independent advisory body to the government, said PSM Healthcare's Paradex (dextropropoxyphene...
Please Login to read the full article.
12 February 2010
Becky Debens
New Zealand's Medicines Adverse Reactions Committee (MARC), an independent advisory body to the government, said PSM Healthcare's Paradex (dextropropoxyphene...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zogenix's long-acting hydrocodone meets chronic pain endpoint, ready for 2012 filing
- US Capitol Capsule: Zombies, doomsday and debt ceilings, oh my
- US Capitol Capsule: In current US budget-cutting climate, was KV naïve in pricing Makena?
- US FDA panel backs expanded use of GSK seizure drug, supports historical controls
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
